A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IV

Clinical trial NCT03755167 · SUSPENDED

Trial details

NCT number: NCT03755167
Sponsor: Immunity Pharma Ltd.
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis (ALS)

Start date: 2018-12-09
Primary completion: 2027-01-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.